Executive Director, Head of Real-World Analytics and Programming
Revolution Medicines - Remote (United States)
Posted Sep 17, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $252K-$315K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $111,944 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +13.7% - Much faster than average
153% above the BLS role benchmark for data and ml aggregate.
Matched to SOC 15-1252 - Data and ML aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Executive Director, Head of Real-World Analytics and Programming Remote (United States) Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity: The Executive Director, Head of Real-World Analytics and Programming will develop and lead Revolution Medicines' real-world analytics and programming capability, setting the strategy, operating model, technical standards, and priorities needed to generate rigorous, decision-ready real-world evidence across the product lifecycle. Reporting to the VP, HEOR/RWE, this leader will partner closely with the Executive Director, Head of Epidemiology & RWD Strategy to align RWD strategy, drive methodologic excellence and optimize the use of data for internal decision making and evidence generation. The role will also collaborate across global and regional HEOR, Clinical Development, Safety, Regulatory, Medical Affairs, Market Access, Commercial Analytics & Insights, and IT to ensure RWE analyses address priority scientific, development, and business needs. Finally, it will be imperative that the ED, RWA&P collaborate strongly with the
Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Associate Director, Real-World Analytics Programming
Revolution Medicines - Remote (United States)
Associate Director, Real World Biostatistics
GSK plc - USA - Pennsylvania - Upper Providence
Senior Director, Global Oncology RWD Platform
AstraZeneca - US - Gaithersburg - MD
Director, Strategic Analytics and Market Research
Summit Therapeutics - Princeton, NJ